Stock Events

Stock Events

KalVista Pharmaceuticals (4XC1.F) Q1 2024 Earnings

11MarConfirmed

Q2 2023

Q2 2023

Q3 2023

Q1 2024

-0.77

-0.74

-0.71

-0.68

Details

Expected EPS

-0.68352331494

Actual EPS

-0.7684487999999999

Surprise EPS

-0.08

Surprise Percent

+12.42%

Description

KalVista Pharmaceuticals (4XC1.F) has reported earnings of -0.7684487999999999 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.